Crohn's disease (CD) is frequently associated with extra-intestinal manifestations (EIMs) and infliximab has been recently proposed for the treatment of CD with EIMs. Our aim was to evaluate the short-term efficacy of infliximab in this treatment.
Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease / Rispo, A; Scarpa, R.; DI GIROLAMO, E; Cozzolino, A; Lembo, G; Atteno, M; Falco, De; T, ; LO PRESTI, M; Castiglione, F.. - In: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. - ISSN 0300-9742. - STAMPA. - 34:5(2005), pp. 387-91-391. [10.1080/03009740510026698]
Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease
RISPO A;R. SCARPA;DI GIROLAMO E;COZZOLINO A;LEMBO G;ATTENO M;DE FALCO;LO PRESTI M;CASTIGLIONE F.
2005
Abstract
Crohn's disease (CD) is frequently associated with extra-intestinal manifestations (EIMs) and infliximab has been recently proposed for the treatment of CD with EIMs. Our aim was to evaluate the short-term efficacy of infliximab in this treatment.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
